Cargando…

miR-200c suppresses endometriosis by targeting MALAT1 in vitro and in vivo

BACKGROUND: Endometriosis is a common, benign, and estrogen-dependent disease characterized by pelvic pain and infertility. To date, the pathogenesis of endometriosis remains unclear. Recent studies have demonstrated that noncoding RNAs, including microRNAs and long noncoding RNAs, play important ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Zongwen, Chen, Yijie, Zhao, Yuan, Xu, Chaoyi, Zhang, Anqi, Zhang, Qiong, Wang, Danhan, He, Jing, Hua, Wenfeng, Duan, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678601/ https://www.ncbi.nlm.nih.gov/pubmed/29116025 http://dx.doi.org/10.1186/s13287-017-0706-z

Ejemplares similares

Silencing of lncRNA MALAT1 facilitates erastin-induced ferroptosis in endometriosis through miR-145-5p/MUC1 signaling
por: Liang, Zongwen, et al.
Publicado: (2022)

miR-206 Targets MALAT1 to Suppress Cell Progression of Ectopic Endometrial Stromal Cells in Endometriosis
por: Li, Jinggang, et al.
Publicado: (2022)

No association between TP53 Arg72Pro polymorphism and ovarian cancer risk: evidence from 10113 subjects
por: Zhang, Anqi, et al.
Publicado: (2017)

Retracted: miR-206 Targets MALAT1 to Suppress Cell Progression of Ectopic Endometrial Stromal Cells in Endometriosis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Baicalin suppresses the migration and invasion of breast cancer cells via the TGF-β/lncRNA-MALAT1/miR-200c signaling pathway
por: Li, Jiafeng, et al.
Publicado: (2022)

Association of polymorphisms in MALAT1 with the risk of endometrial cancer in Southern Chinese women
por: Chen, Guange, et al.
Publicado: (2019)

Circ_0007331 knock‐down suppresses the progression of endometriosis via miR‐200c‐3p/HiF‐1α axis
por: Dong, Lan, et al.
Publicado: (2020)

Zuo Jin Wan Reverses the Resistance of Colorectal Cancer to Oxaliplatin by Regulating the MALAT1/miR-200s/JNK Signaling Pathway
por: Wei, Zhenzhen, et al.
Publicado: (2022)

MALAT1 regulates hypertrophy of cardiomyocytes by modulating the miR-181a/HMGB2 pathway
por: Chen, Feng, et al.
Publicado: (2022)

Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
por: Cufí, Sílvia, et al.
Publicado: (2013)

Integrated Bioinformatics Analysis Reveals Function and Regulatory Network of miR-200b-3p in Endometriosis
por: Hu, Wanxue, et al.
Publicado: (2020)

LncRNA MALAT1 exhibits positive effects on nucleus pulposus cell biology in vivo and in vitro by sponging miR-503
por: Zheng, Hongyu, et al.
Publicado: (2020)

Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
por: Meng, Xiaodan, et al.
Publicado: (2016)

MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS
por: Chang, Junkai, et al.
Publicado: (2018)

RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma
por: Hua, Wen-Feng, et al.
Publicado: (2016)

Atorvastatin Regulates MALAT1/miR-200c/NRF2 Activity to Protect Against Podocyte Pyroptosis Induced by High Glucose
por: Zuo, Yi, et al.
Publicado: (2021)

Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo
por: Mei, Qiang, et al.
Publicado: (2014)

The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility
por: Zhao, Zhiguang, et al.
Publicado: (2018)

miR-200b and miR-200c co-contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases
por: Liu, Jue, et al.
Publicado: (2019)

LncRNA MALAT1 Accelerates Cervical Carcinoma Proliferation by Suppressing miR-124 Expression in Cervical Tumor Cells
por: Liang, Tian, et al.
Publicado: (2021)

A proteomic analysis of an in vitro knock-out of miR-200c
por: Ljepoja, Bojan, et al.
Publicado: (2018)

Targets of miR-200c mediate suppression of cell motility and anoikis resistance
por: Howe, Erin N, et al.
Publicado: (2011)

Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis
por: Duan, Guangchao, et al.
Publicado: (2018)

Helicobacter Pylori Promote B7-H1 Expression by Suppressing miR-152 and miR-200b in Gastric Cancer Cells
por: Xie, Gengchen, et al.
Publicado: (2017)

Gli3 is a novel downstream target of miR-200a with an anti-fibrotic role for progression of liver fibrosis in vivo and in vitro
por: Li, Li, et al.
Publicado: (2020)

The tumor suppressive miR-200b subfamily is an ERG target gene in human prostate tumors
por: Zhang, Zheng, et al.
Publicado: (2016)

The miR-200 family in ovarian cancer
por: Koutsaki, Maria, et al.
Publicado: (2017)

[Retracted] miR‑154 suppresses non‑small cell lung cancer growth in vitro and in vivo
por: Lin, Xingyu, et al.
Publicado: (2023)

WTAP gene variants and susceptibility to ovarian endometriosis in a Chinese population
por: Wan, Zixian, et al.
Publicado: (2023)

LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma
por: Xiao, Haibing, et al.
Publicado: (2015)

MALAT1 regulates miR-34a expression in melanoma cells
por: Li, Fei, et al.
Publicado: (2019)

lncRNA MALAT1 mediates osteogenic differentiation of bone mesenchymal stem cells by sponging miR-129-5p
por: Yin, Junhao, et al.
Publicado: (2022)

MALAT1 promotes gastric adenocarcinoma through the MALAT1/miR-181a-5p/AKT3 axis
por: Lu, Zhengmao, et al.
Publicado: (2019)

Mechanisms and Functions of MiR-200 Family in Hepatocellular Carcinoma
por: Mao, Yinqi, et al.
Publicado: (2021)

miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
por: Tang, Hailin, et al.
Publicado: (2019)

Regulation of miR‐200c and miR‐141 by Methylation in Prostate Cancer
por: Lynch, Seodhna M., et al.
Publicado: (2016)

Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients
por: Kawaguchi, Tsutomu, et al.
Publicado: (2017)

miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis
por: Mansoori, Behzad, et al.
Publicado: (2021)

MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis
por: Wong, Chun-Ming, et al.
Publicado: (2015)

The miR-200 family: multiple effects on gliomas
por: Peng, Lilei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t4f4pc6e75ifedi7l3s4rv34np